跳至主要内容
临床试验/IRCT20180515039673N1
IRCT20180515039673N1招募中3 期

Evaluation of oral product of Carthamus tinctorius effect on cardiovascular risk factors among metabolic syndrome patients

Shiraz University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • Informed and written consent for participation in the study / Body mass index (BMI) above 27 / Having three signs of the five characteristics of the metabolic syndrome based on the definitions of NCEP-ATPIII

排除标准

  • Use of extra- protocol treatments / Use of drugs associated with treatment of metabolic syndrome in the past month / Safflower allergy /positive history of kidney, liver, cancer, thyroid and/or coagulation disease / pregnancy and/or lactation / smoking, alcohol and/or substance abuse / Taking anti-platelet and anticoagulant drugs (such as Aspirin, Clopidogrel, Warfarin, etc.)

研究者

相似试验